ShareHope Medicine Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
November 12, 2023
Share
ShareHope Medicine Co., Ltd. reported earnings results for the third quarter and nine months ended September 30, 2023. For the third quarter, the company reported sales was TWD 969.07 million compared to TWD 1,055.26 million a year ago. Net income was TWD 9.67 million compared to TWD 114.07 million a year ago. Basic earnings per share from continuing operations was TWD 0.08 compared to TWD 0.91 a year ago. Diluted earnings per share from continuing operations was TWD 0.08 compared to TWD 0.9 a year ago.
For the nine months, sales was TWD 2,806.5 million compared to TWD 3,211.51 million a year ago. Net income was TWD 79.86 million compared to TWD 333.3 million a year ago. Basic earnings per share from continuing operations was TWD 0.63 compared to TWD 2.63 a year ago. Diluted earnings per share from continuing operations was TWD 0.63 compared to TWD 2.61 a year ago.
ShareHope Medicine Co., Ltd. is principally engaged in the supply of pharmaceuticals, medical materials and technology materials. The Company is also engaged in the provision of medical health check and medical testing laboratories management consulting and entrusted operation services, the leasing of equipment and the provision of long-term care services. The Company operates its business through five segments: pharmaceutical distribution, health management, technology materials, hospitals and others. The Company distributes its products within domestic market and to overseas markets.
SHAREHOPE MEDICINE CO., LTD. 
